Perkins Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $1.16M | Sell |
224,107
-5,482
| -2% | -$28.4K | 1.4% | 23 |
|
|
2019
Q4 | $1.15M | Sell |
229,589
-6,450
| -3% | -$32.3K | 1.03% | 32 |
|
|
2019
Q3 | $1.88M | Buy |
236,039
+43,314
| +22% | +$344K | 1.62% | 17 |
|
|
2019
Q2 | $1.4M | Buy |
192,725
+500
| +0.3% | +$3.62K | 0.98% | 31 |
|
|
2019
Q1 | $1.54M | Buy |
192,225
+89,125
| +86% | +$713K | 1.01% | 31 |
|
|
2018
Q4 | $825K | Buy |
103,100
+39,300
| +62% | +$314K | 0.64% | 49 |
|
|
2018
Q3 | $983K | Buy |
+63,800
| New | +$983K | 0.59% | 55 |
|